Cerner Corporation company logo

# 1st Gen Model Cerner Corporation Computer integrated systems design

Subscribe >> Deal exit on
Dec. 15, 2017
60.23% successful of 88 deals
$68.57 Last close price
at 14-dec-2017


Model's trade recommendations -4.53% Return for period

-7.05% Annual return

$23.16B Market Cap

β 0.94  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period -4.53%
52wk return -21.70%
52wk Range
Sortino ratio -0.61
Sharpe ratio -0.50
Norm. RMSE 0.48%
Downside risk 11.03%
Volatility 13.44%
  • BUY Analysts consensus recommendation

Cerner Corporation is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. Leveraging the experience of more than three decades in clinical information systems, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care. The company offers Cerner Millennium architecture, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Industry sector: Medical

Sector classification: Computer integrated systems design

Deep Learning based analysis and prediction model for Cerner Corporation (CERN) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for CERN model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 289M
P/E 30.82
Shares Outstanding 332M
% Held by Insiders 13.11%
% Held by Institutions 82.06%
EPS (last reported FY) $2.13
EPS (last reported Q) $0.57
EPS, estimated (last reported Q) $0.58
Total revenues $5 B
Net income $1 B